A Steady Year For The Top Tier In Pharma Ahead Of Major Upheaval

 
• By Jessica Merrill

Moderate growth at Bristol-Myers Squibb and Amgen moved the two companies into the top 10 pharma ranks, based on the most recent Scrip 100 rankings, while declining growth at Gilead and Teva moved those drug makers out.

IV1912_Scrip-100_Upheaval_572140570_1200.jpg
Change on the horizon for big pharma • Source: Shutterstock

More from Financing

More from Business